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Abstract
Reengineering protein surfaces to exhibit high net charge, referred to as ‘‘supercharging’’, can improve reversibility of
unfolding by preventing aggregation of partially unfolded states. Incorporation of charged side chains should be optimized
while considering structural and energetic consequences, as numerous mutations and accumulation of like-charges can also
destabilize the native state. A previously demonstrated approach deterministically mutates flexible polar residues (amino
acids DERKNQ) with the fewest average neighboring atoms per side chain atom (AvNAPSA). Our approach uses Rosetta-
based energy calculations to choose the surface mutations. Both protocols are available for use through the ROSIE web
server. The automated Rosetta and AvNAPSA approaches for supercharging choose dissimilar mutations, raising an
interesting division in surface charging strategy. Rosetta-supercharged variants of GFP (RscG) ranging from 211 to 261 and
+7 to +58 were experimentally tested, and for comparison, we re-tested the previously developed AvNAPSA-supercharged
variants of GFP (AscG) with +36 and 230 net charge. Mid-charge variants demonstrated ,3-fold improvement in refolding
with retention of stability. However, as we pushed to higher net charges, expression and soluble yield decreased, indicating
that net charge or mutational load may be limiting factors. Interestingly, the two different approaches resulted in GFP
variants with similar refolding properties. Our results show that there are multiple sets of residues that can be mutated to
successfully supercharge a protein, and combining alternative supercharge protocols with experimental testing can be an
effective approach for charge-based improvement to refolding.
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Introduction
Reengineering protein surfaces to have increased net charge can
prevent ordered and disordered aggregation of partially unfolded
states [1,2]. Charge repulsion interactions disfavor two or more
proteins coming into close proximity and subsequently aggregating
via specific [3,4,5,6] or non-specific [7] interactions. Net charge,
rather than number of charged residues, is a major determinant of
aggregation propensity [8,9], and ‘‘supercharging’’ proteins to
have increased net charge can thus prevent aggregation and
promote appropriate refolding.
Aggregation is a common obstacle for protein applications in
biotechnology and medicine. In medicine, preventing aggregation
can improve the consistency and bioavailability of therapeutics,
facilitate production and storage, safeguard drug activity, and curb
immunogenicity [10]. Methods for inhibiting protein aggregation
have been highly sought to improve biopharmaceuticals, from
rational design to introduction of excipients [11,12,13]. For
example, human calcitonin is a small peptide hormone required
for calcium regulation and bone formation that is prone to forming
amyloid fibrils. Calcitonin was redesigned with several mutations
to arginine and lysine, and the resulting variant showed
significantly reduced aggregation propensity and maintained/
improved potency [14].
In biotechnology, sequestration of poorly soluble or readily
misfolded proteins into inclusion-bodies is a bottleneck for
expression and purification [15]. Enteropeptidase light chain
cleaves trypsinogen into active trypsin and is used in various
biotechnology applications, but it has poor solubility and refolding
properties. Recent work by Simeonov et al. demonstrated that five
mutations increasing the net charge from 23 to 29 resulted in
improved in solubility and refolding yield without affecting
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structure or activity [16,17]. Increasing net charge using surface
mutations can also improve refolding of more complex proteins
with limited plasticity, such as antibodies. While single-chain
variable fragment antibodies (scFVs) have diverse applications,
they show a tendency to aggregate upon unfolding [18].
Refrigeration is a necessary complication for storage, and even
brief exposures to high temperature may cause irreversible
unfolding of the scFV. Lyophilization is commonly used for long-
term storage of proteins though this does not prevent aggregation
upon rehydration [19]. Our previous work in supercharging scFVs
demonstrates that after exposure to high temperature, a super-
charged scFV variant refolds and retains epitope binding, in
contrast to the wild type parent [20].
Apart from promoting refolding, there are additional motiva-
tions for adding charges to protein surfaces. In the context of viral
pathogenesis, it was discovered that highly cationic proteins and
peptides are capable of facilitating cellular uptake [21]. While
multiple groups have examined ‘natural’ cationic proteins such as
HIV-Tat and antennapedia, others have employed ‘arginine-
grafting’ as an approach to impart this function [22]. There is
great interest in this field as protein-based nonviral cell entry can
mediate intracellular delivery of therapeutic and antimicrobial
biologics [23,24,25,26,27].
Additionally, engineering proteins to alleviate aggregation may
lead to improved understanding of aggregation mechanisms and
development of new strategies to prevent and treat diseases caused
by protein aggregation [28]. Amyloid, prion, polyglutamine, and
sickle-cell are aggregation-based diseases (reviewed in [29]).
Recently, a study by Xu et al. implicated aggregation of p53
mutants in uncontrolled cell growth, and mutation of an isoleucine
to arginine helped offset aggregation [30].
Adding charge to proteins can prevent aggregation, but it can
also destabilize the folded state. Choosing which residues to
mutate while retaining the native structure is a critical step in
supercharging proteins. One approach explored by the David Liu
group mutates the most highly solvent-exposed flexible polar
residues, assuming that these positions will be able to accommo-
date any charged side chain [31]. This method, called AvNAPSA
(Average number of Neighboring Atoms Per Side-chain Atom) has
been used successfully in some cases. For example, variants of
sfGFP, streptavidin, and glutathione S-transferase demonstrated
improved solubility after heating and improved retention of
fluorescence or activity after heating to 100uC [31]. It should be
noted that supercharging of the latter two proteins, while
imparting thermal resilience, negatively impacted function. In
further investigation of this method, the AvNAPSA approach for
supercharging an scFV did not lead to variants that could retain
epitope binding after 70uC exposure for 1 hour.
One drawback of the automated AvNAPSA approach is that
mutation of surface hydrophobic residues is disallowed, and
decreasing the hydrophobic residue content is one route to
alleviating aggregation [1]. Secondly, b-sheet propensity is another
leading determinant of aggregation [32], and the automated
AvNAPSA approach disallows mutation of I, V, T, F, and Y
residues with high b-sheet propensity. Thirdly, solvent-exposed
side chains sometimes form stabilizing contacts on the protein
surface. For example, in the supercharged anti-MS2 scFV, the
AvNAPSA protocol mutated a solvent-accessible native aspartate
to arginine, though the aspartate side chain is predicted to form a
hydrogen bond with a backbone amide in a surface loop [20]
(Figure S1). A small percentage of surface-exposed residue
mutations can still have significant deleterious effects on stability.
In studies of ubiquitin, removal of charge-charge interactions
ranged from having no effect to decreasing stability by several
kcal/mol [33], [34]. Such variations, in addition to possible
cooperative energetic effects [35], result in a weak correlation
between accessible surface area and DDG of folding [36]. Most
experimental DDG values for surface-exposed mutations fall
between 21 and +2 kcal/mol [36]. These magnitudes are
significant, especially upon heavy mutagenesis, compared to the
marginal stability of most proteins. Thus, an automated strategy
that removes surface interactions can work in some cases but not
others.
Our approach to supercharging explicitly considers surface
interactions when identifying acceptable residues for mutation. We
employ the Rosetta computational modeling software [37,38] to
choose the residue positions and charged residue type to
incorporate based on computed energies. The major terms of
the full-atom energy function are Lennard-Jones attraction,
Lennard-Jones repulsion, an implicit solvation model disfavoring
burial of polar groups, hydrogen bonding, a statistical residue pair
term for electrostatics, side-chain rotamer probability, and a
reference energy used to favor native-like abundance of each
amino acid type [39]. Thus, the Rosetta approach can preserve
and potentially add stabilizing interactions on the surface while
increasing net charge (Figure S1). In the Rosetta supercharging
protocol, we use the score12 full-atom energy function [40] and
manipulate the reference energies for arginine, lysine, aspartate,
and glutamate to achieve varying levels of net charge (see
Methods).
We ran Rosetta and AvNAPSA supercharging algorithms on
600 monomeric proteins from the Protein Data Bank and
observed that the Rosetta protocol and AvNAPSA protocol give
highly different designed sequences. To gauge the effectiveness of
the Rosetta supercharge protocol, we characterized the expression,
stability, and refolding of a series of GFP charge variants
(Figure 1). Thermal denaturation of GFP results in irreversible
aggregation, likely due to intermolecular b-sheet formation
[41,42]. Additionally, the absorbance and fluorescence signatures
of the GFP chromophore provide a convenient way to monitor
correct folding [43,44], and GFP has been previously super-
charged using the AvNAPSA solvent-accessibility approach [31].
Our results show that despite having highly different designed
sequences, Rosetta supercharged GFP variants had similar
expression, stability, and refolding properties as the AvNAPSA
variants.
Methods
AvNAPSA Supercharge
Here we discuss two automated methods for supercharging,
energy-based sampling with Rosetta and surface exposure
rankings with AvNAPSA. The computational workflow in
Figure 2 illustrates the descriptions that follow. The previously
demonstrated AvNAPSA supercharging protocol mutates the most
highly solvent accessible NQ and DE/RK residues, where solvent
accessibility is determined by the average neighbor atoms per side
chain atom (AvNAPSA value) [31]. We implemented the
AvNAPSA protocol within Rosetta, and to achieve a target net
charge, the following workflow is used (Figure 2). First, all NQ
and RK/DE residues are sorted by AvNAPSA value from low to
high. One by one, the next residue in this sorted list is added to the
list of mutations that will be made to the protein. If the user does
not want specific residues to be mutated, this can be specified in an
input file. Positive supercharging uses DENQ to K mutations, and
negative supercharging uses RKQ to E and N to D mutations.
Once the desired net charge is achieved, the Rosetta PackRotamers
mover for sequence design uses the mutations list to generate the
Supercharging Protein Surfaces for Refolding
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final sequence for output as a PDB coordinate file containing
calculated residue energies. An alternative AvNAPSA mode is also
available, where instead of specifying a target net charge, the user
can specify a surface cutoff – AvNAPSA values ,150 were used
previously [31], AvNAPSA values ,100 are appropriate for
moderate supercharging.
Rosetta Supercharge
Mutations of the most exposed residues will often impart
minimal changes to the protein structure. However, by not
considering energetic consequences of mutation, this approach
may mutate surface residues involved in backbone or side-chain
hydrogen bonds, negatively impacting overall stability. For
example, D residues can interact with amide protons in turn/
loop regions on the surface and N residues can cap either end of
an alpha helix. Also, the AvNAPSA approach has been shown to
miss opportunities to add stabilizing mutations by mutating
partially buried residues (Figure S1). We propose an alternative
strategy for supercharging surfaces that uses computed energy to
choose mutations.
In the Rosetta approach, as with the AvNAPSA approach, the
first step is to define the surface. This can either use the AvNAPSA
surface definition, or the standard metric used in Rosetta – Rosetta
typically defines surface residues as those having fewer than 16
neighboring residues with Cb-Cb distances ,10 A˚ [45]. Using Cb
residue-based distances, the surface definition is insensitive to side-
chain conformation or sequence changes. Surface definitions
between the atom-based or residue-based neighbor calculations
are noticeably different (R2 = 0.85, Figure S2), Rosetta super-
charge uses the AvNAPSA surface definition by default. If the user
wishes to not restrict mutations to the calculated surface – for
example, a seemingly buried residue position could accommodate
an arginine side chain that bends toward the surface – the surface
definition can be increased to a residue neighbor cutoff of 30 or an
AvNAPSA value of 200 to include peripheral or buried residues.
The next step of Rosetta supercharge is to set the design ‘‘task’’,
which specifies what amino acids are allowed or not allowed at
each residue position. Residue positions included in a residue file,
if provided by the user, will not be mutated (Text S1). This would
be desirable if a known binding surface is important for function,
or if a homology model is the only available starting structure.
Starting from a homology model, mutating surface hydrophobic
residues would be risky since these positions could actually be part
of the core. Additional residues will also be preserved by default:
those with the correct charge, those with side chains making a
hydrogen bond (calculated hbond energy,20.5 Rosetta energy
units), and glycine, proline, and cysteine residues. The user can
turn off any of these restrictions if desired.
The Rosetta supercharging protocol uses computed energies to
choose surface mutations, and for this work, we use the score12
Rosetta energy function. Variations of the Rosetta energy function
are used for special scenarios, such as DNA-protein interactions
[46], consideration of hydrophobic patch size [45], low-resolution
stages of protein folding [39], and incorporating constraints from
experimental data [47]. However, for choosing surface mutations,
we use the common-use energy function called score12. Although
recent work has been done to optimize the Rosetta energy
function [48], score12 has been the most consistently used and
validated energy function for a variety of design goals.
The AvNAPSA approach varies net charge by adjusting the
surface cutoff. In contrast, the Rosetta approach varies net charge
Figure 1. Illustration of supercharged GFP surfaces. The GFP backbone is shown in green cartoon, Asp/Glu side chains are shown in red
spheres, Arg/Lys side chains are shown in blue spheres. Left: mutations in negatively-supercharged variants. Center: wild-type superfolding GFP.
Right: mutations in positively-supercharged variants.
doi:10.1371/journal.pone.0064363.g001
Figure 2. Workflow of two protocols for supercharging protein
surfaces. Both protocols begin by defining the surface of the protein
of interest, and if provided, reading a residue file that specifies residues
to not mutate. AvNAPSA forcibly mutates NQ and DE/RK in order of
solvent accessibility. Rosetta uses Monte Carlo side chain placement
guided by computed energies to mutate any surface residue except G,
P, C, and hydrogen-bonded side chains, and charged-residue reference
energies are adjusted to vary net charge. Both protocols are set up to
achieve a desired net charge (above), or to specified reference energies
(Rosetta) or surface cutoff (AvNAPSA). Output includes the PDB
coordinate file of the redesigned protein, the residue file specifying
the allowed mutations, and a log file with information such as residues
mutated, number of mutations, net charge, residue energies, and a
PyMOL selection command to conveniently view the mutations.
doi:10.1371/journal.pone.0064363.g002
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by adjusting reference energies of the positive or negatively
charged residue types when scoring protein sequences and
conformations. The Rosetta energy function uses reference
energies for all 20 amino acid types to provide residue bonuses/
penalties that enable benchmark sequence recovery simulations to
recapitulate residue frequencies in native proteins. In Rosetta
supercharge, the reference energies for any of the included
charged residue types can be specified, but the reference energies
of the native residue types cannot be changed. The default weights
in the score12 Rosetta energy function for R, K, D, and E are
20.98, 20.65, 20.67, and 20.81, respectively, but should be
adjusted to give a spectrum of net charges (Figure 1, Figure S3).
If desired, reference energies can be used to bias the choice
between R v. K or D v. E. Alternatively, the user can specify a
target net charge, and the protocol will iteratively increment the
charged-residue reference energies until the desired net charge is
achieved. Fixed backbone side chain placement of surface residues
is often highly convergent, but the process is still stochastic so
several runs can be performed using the ‘nstruct’ option. To
summarize, the standard Monte Carlo PackRotamers mover and
score12 Rosetta energy function govern the choice of mutations,
but the reference energies can bias the choices to more or fewer
charge mutations.
ROSIE Supercharge Web Server with Rosetta and
AvNAPSA Modes
Web servers have offered convenient and user-friendly access to
Rosetta protocols [49,50,51]. The ROSIE web server (Rosetta
Online Server Including Everyone) now provides a unifying
framework for server implementation of Rosetta protocols [52].
To make both supercharging protocols broadly available, we
implemented both protocols on the ROSIE web server (Figure 3).
The AvNAPSA protocol can also be obtained as a perl script upon
request from the Liu lab [53].
The supercharge protocol requires an input PDB in which all
backbone atoms and a chain identifier should be present, and any
unrecognized residues such as ligands will be ignored. The user
can specify various options to use Rosetta or AvNAPSA mode,
define the surface, choose a target net charge, and upload a
residue file (resfile, Text S1); all options are listed in Table 1. We
recommend that the user considers the starting net charge of the
protein prior to supercharging: for input proteins starting with a
negative net charge and low pI, negative supercharging will
require fewer mutations to impart high net charge, and vice-versa.
As output, a log file, the residue file that governed the design run,
and the output PDB are provided. First, the log file contains the
exact Rosetta command line, the residue positions identified as
located on the surface, the number of each charged residue type in
the final sequence, the net charge, a list of mutations, text for a
Figure 3. User interface for running the supercharge protocol on the ROSIE web server. The user uploads a PDB, then uses checkboxes or
sliding bars to specify the protocol options, not all options are shown here (Table 1). Job status and protocol documentation can be viewed in the
Queue and Documentation tabs.
doi:10.1371/journal.pone.0064363.g003
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PyMOL selection to easily view the mutations in PyMOL, and
optionally, a full energetic comparison of repacked native versus
supercharged structures. Secondly, the Rosetta residue file
indicates which residue positions could possibly mutate, and to
what residue types. The third output file is the atomic coordinate
file of the supercharged protein, in PDB format, and the naming of
the output PDB is intended to facilitate self-documentation of the
inputs for a given design run. For Rosetta designs, the name
includes the final reference energies and the final net charge, and
for AvNAPSA designs, the name includes the net charge and the
largest AvNAPSA value of the mutated residues.
Results
Computed Energy Comparison between Rosetta and
AvNAPSA Approaches
The philosophy of the AvNAPSA supercharge approach is to
minimize risk of perturbing the native structure while adding
charged residues. The philosophy of the Rosetta supercharge
approach is to maintain and possibly improve surface interactions
while adding charged residues (Figure 4A). Using both approach-
es, large-scale positive- and negative-supercharging design runs on
600 proteins show how well each protocol accomplishes its goal,
computationally. First, low-charge designs were generated with
Rosetta using the default reference weights without specifying a
target net charge; Rosetta could choose a charged residue or the
native residue at each surface position. Then, for all 600 proteins,
AvNAPSA was run to achieve the previous Rosetta net charges.
Secondly, high-charge designs were generated with AvNAPSA
using no target net charge and fixed surface cutoff (AvNAPSA
value ,150 as used previously [31]), then Rosetta was run to
achieve the AvNAPSA-150 net charge for all 600 proteins. The
low-charge variants averaged ,7 mutations per structure, and the
high-charge variants averaged ,30 mutations per structure
(Figure S4, Table S1).
In low-charge variants, the AvNAPSA approach on average has
minimal effect on computed energies, except for an improved
solvation energy for positive supercharging, which results from
populating the highly exposed positions with lysines (Figure 5). In
high-charge variants, however, the AvNAPSA approach removes
attractive interactions, adds repulsive interactions, and places like-
charges in close proximity (Figure S4). Also, several surface
hydrogen bonds per structure are lost (Figure 6, Figure 7). The
specific examples in Figure 7 are for illustrative purposes; on
average, high-charge AvNAPSA designs removed 3 strong
hydrogen bonds and 8 weak hydrogen bonds per structure.
High-charge Rosetta designs added 0.25 strong hydrogen bonds
and 1.6 weak hydrogen bonds per structure (Table S1). As
expected, the Rosetta approach improves the Rosetta scores
because it chose mutations based on these computed scores
(Figure 5). The Lennard-Jones attractive term and the knowl-
edge-based pair term show improvements – the pair term favors
placing oppositely-charged residues near each other. Hydrogen
bonding improves only slightly (Figure 5, Figure S5, Table S1).
These changes in computed energy are informative but
expected. The striking comparison between these two approaches
Table 1. Rosetta supercharge options.
Either option default
bool target_net_charge_active false
int, signed target_net_charge 0
int, unsigned surface_atom_cutoff 120
file resfile N/A
bool pre_packminpack false
bool compare_residue_energies_all false
bool compare_residue_energies_mut true
Rosetta
int, unsigned surface_residue_cutoff 16
bool include_arg false
bool include_lys false
bool include_asp false
bool include_glu false
float refweight_arg 20.98
float refweight_lys 20.65
float refweight_asp 20.67
float refweight_glu 20.81
int, unsigned nstruct 1
bool preserve_glyprocys true
bool preserve_hbonded_sidechains true
bool preserve_correct_charge true
AvNAPSA
bool AvNAPSA_positive false
bool AvNAPSA_negative false
doi:10.1371/journal.pone.0064363.t001
Figure 4. Rosetta and AvNAPSA supercharge protocols mutate
different residues. A) AvNAPSA-mutated residue positions (white)
are highly exposed and are often in loop regions, while Rosetta-
mutated residue positions (blue) are less exposed and two mutations
are in stable secondary structures. Native side chains of the mutated
positions are shown in spheres to convey that Rosetta can mutate
hydrophobic and small-polar residues. We emphasize that no mutations
are shared between the two approaches in this low-charge design. B)
Moderate supercharging was performed on 600 monomeric proteins,
and the mutated residues were compared – each monomer was
designed with the same net charge in both approaches. Rosetta
requires more mutations to achieve the same net charge (solid v.
empty). For negative-charge designs, 9% of mutated residue positions
are shared (black, left). For positive-charge designs, 6% of mutated
residue positions are shared (black, right). Shared mutations decrease
an additional ,2-fold considering that the chosen residue type differs
,50% of the time for the shared residue positions – AvNAPSA never
uses arginine, and AvNAPSA only uses aspartate if the native residue is
asparagine.
doi:10.1371/journal.pone.0064363.g004
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is the extent of dissimilarity between chosen mutations. For low-
charge supercharging, the two approaches only share 6–9% of
mutated residue positions (Figure 4B). Furthermore, the shared
mutations decrease by about half when only counting residue
positions that were mutated to the same residue type. Why do
these two surface redesign protocols diverge to such a great extent?
In positive supercharging, Rosetta can mutate 15 amino acid
types: DE-NQ-ASTHMVLIYFW, while AvNAPSA can mutate 4
amino acid types: DE-NQ (Figure S6). This effectively allows
AvNAPSA to build a higher charge with a lower mutational load
(Figure S8), but it allows Rosetta more choices for energetically
favorable mutations. Secondly, among the DE-NQ residues that
both protocols are allowed to mutate, Rosetta is inclined to mutate
partially buried positions (Figure S7) that can add additional van
der Waals contacts, charge complementarity, or hydrogen bonds,
while AvNAPSA attempts to ‘‘leave-not-a-trace’’, to have minimal
effect on protein surface contacts (Figure 4). Thirdly, the fully
automated AvNAPSA protocol only uses K while Rosetta uses K
and R for design.
Expression and Foldedness of Supercharged GFP Variants
We observed that the Rosetta and AvNAPSA protocols for
supercharging lead to highly dissimilar designed sequences. We
then experimentally characterized a series of positive- and
negatively-supercharged variants of GFP from the Rosetta
approach (RscG). Here we demonstrate that a highly dissimilar
computed energy-based method can also lead to improved
refolding, but we add caution that severe mutagenesis and/or
Figure 5. Low-charge variant residue energy changes per structure (600 total) broken down by each weighted score term. Red:
negative-charge variants. Blue: positive-charge variants. Solid bars: Rosetta designs. Empty bars: AvNAPSA designs. AvNAPSA mutations have
little effect on computed energy, on average (right, empty bars). Rosetta improves total energy primarily through Lennard-Jones attraction (fa_atr),
charge complementarity (fa_pair), and reference energy, and a minor improvement results from addition of hydrogen bonds (left, solid bars). Rosetta
mutations lead to increases in solvation energy (fa_sol) for negative supercharging. Not all score terms are included because their values cannot
change in fixed backbone design (backbone-backbone hydrogen bonds, disulfides, proline closure, omega angle planarity). total: total residue
energy, fa_atr: Lennard-Jones attraction, fa_rep: Lennard-Jones repulsion, fa_sol: Lazaridus-Karplus implicit solvation (penalizes buried polar atoms,
slightly rewards buried carbon atoms), fa_pair: knowledge-based statistical term favoring oppositely-charged residues in close proximity,
hbond_bb_sc: geometric score for backbone-sidechain hydrogen bonds, hbond_sc: geometric score for sidechain-sidechain hydrogen bonds.
doi:10.1371/journal.pone.0064363.g005
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charge (.33 mutations, higher than +40 or 243 in this study),
even when limited to the surface, is likely to impair expression and
proper folding. We note that the previously described AvNAPSA
GFP variants (AscG230 and AscG+36) were not actually designed
using the fully-automated AvNAPSA approach described above,
though AvNAPSA values were the primary input for choosing
residue mutations. Visual inspection was also used, and AscG230
was derived from a library screen that mixed wild-type and
AscG239 oligonucleotides because AscG239 did not express
[31]. Thus, the experimental results are not rigorous comparisons
between methods, but the AscG230 and AscG+36 variants offer a
metric of success for evaluation of Rosetta variants.
We tested RscG variants ranging from 211 to 261 and +7 to
+58 with the number of mutations ranging from 6 to 49 (Table 2).
For reference, the starting net charge of wild-type superfolder GFP
(sfWT) is 26 [54]. Detailed methods of GFP construct assembly
and expression are given in Text S1. Auto-induced bacterial
cultures were grown (24 hours, 37uC) and normalized according to
absorbance at 600 nm. Following sonication and centrifugation,
each cleared lysate was scanned at emission/excitation wave-
lengths of 488/509 nm to gauge the level of expressed, correctly
folded soluble GFP. Wild-type sfGFP and negative variants
extending to charges of 224 expressed comparably well
(Figure 8A). Expression levels dropped precipitously beyond this
net charge (variants RscG232 to RscG261, as well as AscG230).
Moderate expression was observed with positively charged
variants ranging from +7 through +40, while the RscG+44 and
RscG+58 designs expressed poorly. Again, the AvNAPSA variant
AscG+36 exhibited expression similar to its Rosetta counterpart,
RscG+35. These experiments were performed in physiological salt
concentrations of 150 mM. Resolubilization of the insoluble pellet
in 5 M NaCl recovered a large fraction of properly folded,
fluorescent protein, particularly in the higher net positive charge
range (Figure S9). As a second measurement of correct folding,
the GFP variants were purified and ratios of absorbance at
488 nm (folded GFP) versus absorbance at 280 nm (total protein)
were determined. Most Rosetta supercharged variants had similar
A488/A280 ratios as sfWT except for the high-charge negative
variants RscG232 to 261 and the highest-charge positive variant
RscG+58 (Figure 8B).
Stability and Refolding of Supercharged GFP Variants
Following purification by immobilized metal ion affinity
chromatography, supercharged variant concentrations were nor-
malized to 2 mM by A280. GFP fluorescence was monitored during
thermal denaturation to assess the impact of Rosetta supercharg-
ing on stability. Moderately charged variants up to RscG224 and
RscG+31 exhibited melting transitions within 5uC of wild type.
RscG negatively-charged variants were more stable than the
AscG230 variant, which supports the use of computed energies to
choose mutations. Beyond RscG232 and RscG235, the more
highly negative charges of 243 and 248 showed significantly
impaired stability (Figure 9A). In contrast, the positively
supercharged variants were more robust, a charge of +44 was
reached before severe destabilization occurred (Figure 9B).
Additional experiments were performed to assess refolding after
thermal denaturation. 2 mM samples of the GFP variants were
measured for initial fluorescence, then heated to 95uC for 1 to 5
minutes, then monitored for fluorescence recovery at room
temperature over the course of 20 minutes. The length of
incubation at 95uC significantly impacted recovered fluorescence
– for wild-type, 60% recovery occurred after 1 minute of heating,
compared to 8% after 3 minutes and ,5% after 5 minutes of
heating (Figure S10). Similar trends were observed for super-
charged variants, though the effect of incubation time was not as
pronounced. Recovered fluorescence increased for negatively
supercharged variants up to RscG232, after which RscG237
and RscG243 appeared not to refold at all (Figure 10).
RscG232 exhibited a 50% recovery in fluorescence, similar to
the 39% recovery of AscG230 (Figure S11). For positively
supercharged variants, charges up to +40 were well tolerated and
did not negatively impact refolding. However, only two variants,
RscG+15 and RscG+22 improved fluorescence recovery to 40%
and 20%, respectively. RscG+35 exhibited 6% recovery, and
AscG+36 exhibited 20% recovery (Figure 10).
Discussion
Supercharging protein surfaces should aid a variety of
applications, such as improving thermoresistance and refolding
Figure 6. High-charge variant hydrogen bond energy changes
per structure (600 total). In high-charge AvNAPSA designs (AvNAPSA
cutoff of 150), removal of hydrogen bonds costs 1.5 to 3 Rosetta energy
units per structure (empty bars). In contrast, Rosetta designs with the
same net charge preserve hydrogen bonds (solid bars).
doi:10.1371/journal.pone.0064363.g006
Figure 7. Specific examples of hydrogen bonds removed by
AvNAPSA supercharge. In AvNAPSA designs, wild-type surface
residues forming hydrogen bonds can be mutated (white sticks show
the native side chain). A) Mutation of surface NQ/DE/RK residues can
lead to loss of hydrogen bonds. B) Common sidechain-backbone
hydrogen bonding motifs at protein surfaces mediate direct interaction
with secondary structure elements and interaction with regions that
transition between secondary structure elements. N and Q residues can
act as both donor and acceptor, illustrating the risk of automated N to D
and Q to E mutations.
doi:10.1371/journal.pone.0064363.g007
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yield [16,20,31], and in the case of positively supercharged
proteins, enabling cellular entry [27,53]. Supercharging is
challenging because the deleterious effects of successive mutations
eventually overcome the plasticity of a surface and hamper protein
function. In contrast to an approach based on surface exposure
only, the Rosetta supercharge protocol uses computed energy to
Table 2. Mutations and net charge of supercharged GFP variants.
Protein Reference energy 1 Reference energy 2 Net charge # mutations D computed energy**
sfWT 26 0 0
RscG211 20.27 20.41 211 6 23.5
RscG215 20.42 20.56 215 9 24.2
RscG218 20.52 20.66 218 11 25.2
RscG224 20.67 20.81 224 15 25.7
RscG232 20.82 20.96 232 20 24.6
RscG237 20.97 21.11 237 23 23.5
RscG243 21.22 21.36 243 28 21.8
RscG248 21.42 21.56 248 33 +0.9
RscG252 21.67 21.81 252 36 +3.5
RscG261 21.67* 21.81* 261 49 +6.2
RscG+7 20.74 20.41 +7 9 25.3
RscG+11 20.94 20.61 +11 12 24.6
RscG+15 21.09 20.76 +15 15 24.6
RscG+22 21.14 20.81 +22 19 24.0
RscG+27 21.19 20.86 +27 22 23.6
RscG+31 21.24 20.91 +31 25 21.9
RscG+35 21.34 21.01 +35 28 20.6
RscG+40 21.54 21.21 +40 32 +0.8
RscG+44 21.79 21.46 +44 35 +2.9
RscG+58 21.99* 21.66* +58 47 +6.0
AscG230 230 15 +4.5
AscG+36 +36 29 +6.9
*hydrogen bonded side chains allowed to mutate.
**with default reference energies.
doi:10.1371/journal.pone.0064363.t002
Figure 9. Stability measurements using thermal denaturation
while monitoring GFP fluorescence. A) negative-charge variants.
B) positive-charge variants. Rosetta-based designs retain thermostabil-
ity within 10uC of sfWT, except for the variants requiring severe
mutagenesis (.33 mutations).
doi:10.1371/journal.pone.0064363.g009
Figure 8. Expression and relative folding of supercharged GFP
variants. A) Total fluorescence values indicate the level of expression
of correctly folded GFP. The low- to mid-charge negative variants
expressed well, but mid- to high-charge variants expressed significantly
worse that sfWT. B) Absorbance ratios indicate the relative amount of
correctly folded GFP. Absorbance by the chromophore at 495 nm
indicates correctly folded GFP, and absorbance at 280 nm indicates the
total amount of GFP. Low- to mid-charge variants are well folded
(before thermal challenge), while high-charge variants are not well
folded.
doi:10.1371/journal.pone.0064363.g008
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introduce mutations, potentially avoiding decrements in stability
and leading to more functional supercharged proteins.
We have previously used Rosetta to both positively and
negatively supercharge antibodies [20] and wished to further
show the generality of this method. In this regard, green
fluorescent protein was an especially attractive target for
engineering due to its common use, fluorescence readout, and
poor refolding. In addition, we sought to better understand
determinants of charge-dependent refolding by comparing our
Rosetta energy-based approaches with the AvNAPSA residue-
exposure supercharging method that had previously been applied
to GFP [31]. Although certain Rosetta variants showed slightly
better thermostability and fluorescence recovery than AvNAPSA
variants, marginal differences in a study of limited scope cannot
substantiate claims that one method outperforms the other. The
goal of this study was to propose an alternative approach to a
previously demonstrated approach.
Both supercharging methods have their advantages and
disadvantages. The AvNAPSA approach requires fewer mutations
to achieve the target net charge due to higher likelihood of a
charge swap – AvNAPSA only requires 0.6 mutations per charge
while Rosetta requires 0.85 mutations per charge, on average
(Figure S8). However, the Rosetta approach can mutate exposed
hydrophobic residues to charged polar residues, and removing
surface hydrophobic residues can help prevent aggregation of
partially unfolded states. As a caveat, the expanded choice of
positions to mutate may lead to the inadvertent discovery of
destabilizing mutations, especially with wild-type residues that are
partially buried. AvNAPSA mutations can also be destabilizing,
due to loss of sidechain-sidechain and sidechain-backbone
hydrogen bonds when mutating exposed residues. Several
common surface sidechain-backbone hydrogen bonding motifs
are important for structure and stability: 1) direct interaction with
secondary structure elements: edge-strand interaction, helix
capping, loop stabilization; and 2) interaction with transitions
between secondary structure elements: stand entry/exit, helix
entry/exit, tight turns between secondary structures (Figure 7).
Furthermore, N and Q residues can serve simultaneously as
donors and acceptors, and in these cases mutation to D and E are
destabilizing (Figure 7). Lastly, Rosetta can choose between
arginine and lysine and preserve/add stabilizing interactions
unique to arginine [55,56,57], while the automated AvNAPSA
approach uses only lysine.
Although native surface hydrogen bonds are safeguarded by
computed energies, surface interactions remain challenging to
accurately model and score. Likely magnified in supercharged
designs, one major gap in the current Rosetta scoring function is
the lack of a physics-based term to describe long range
[58]electrostatic interactions. Electrostatic calculations that solve
the Poisson-Boltzmann equation are computationally expensive
and cannot be evaluated using rapid pair-wise scoring. Instead,
Rosetta uses a knowledge-based pair term that disfavors placing
like-charged residues and favors placing oppositely-charged
residues in close proximity. This knowledge-based pair term
crudely captures cation-pi interactions between arginine and
aromatic residues [59], but there is currently not a cation-pi term
in the Rosetta score function.
Thus, there are two different strategies for supercharging a
surface: partially capture surface energetics (Rosetta), or ignore
error-prone energy calculations and attempt to minimize the
mutagenic footprint (AvNAPSA). The Rosetta and AvNAPSA
protocols (Rsc and Asc) diverged when choosing surface muta-
tions, but both protocols led to GFP variants with improved
refolding. Many RscG variants retained native-like stability, while
the AscG230 variant was destabilized. In general, variants with
intermediate net charges (20–30 net charge for a 28 kDa protein)
tended to refold better than low- or high-charge variants.
However, we were not able to pinpoint more precise reasons that
some designs worked better than others. For example, variant
RscG232 demonstrated the best refolding, while variant
RscG237 did not refold. Our protocols were not uniformly
successful because consequences of mutations are challenging to
predict. Even when only mutating two residues, energy changes
upon removing or adding charge-charge interaction on protein
surfaces can vary highly depending on the protein [1,33,34,60,61],
and on location on the protein surface [34]. Furthermore, the risk
of mutating a critical surface residue increases with more
mutations. The number of mutations can be limited by adding
like-charges according to the starting net charge or pI rather than
reversing the charge sign of the input protein. In our study, 20+
mutations decreased expression yield and stability. Consistent with
these observations, the initial negatively supercharged GFP variant
designed by AvNAPSA, AscG239, contained 20 mutations, but
did not express well in E. coli.
Because of these uncertainties in surface energy calculations,
optimal net charge, and consequences of mutating many residues,
another possible approach to improve refolding of a target protein
is to augment computational design with directed evolution or
high-throughput screening. In fact, the AscG230 variant was
generated by a randomization and screening approach. Since the
negatively supercharged AscG239 variant did not express in E.
coli, it was shuffled with wild-type GFP to generate a library. This
library was screened by picking fluorescent colonies for sequenc-
ing, and the most fluorescent variant had 15 of the original 20
mutations [31,53].
In summary, we have developed a Rosetta-based protocol for
supercharging protein surfaces. GFP variants with intermediate
net charges (20–30 net charge for a 28 kDa protein) tended to
refold better than low- or high-charge variants. We conclude that
computational methods to find the best sequence for refolding are
partially successful, and for future uses of supercharging to
improve refolding, we recommend testing a series of variants or
combining computational design with high-throughput screening
to identify successful variants.
Supporting Information
Figure S1 Motivation for considering surface interac-
tions when choosing charge mutations. Above are compu-
tational models of scFv supercharge designs. Left: By only
considering solvent accessibility, surface hydrogen bonds may be
Figure 10. Percent recovery of fluorescence after heating GFP
variants to 956C for 3 minutes. All variants were tested at 2 mM
concentration. Some variants demonstrated poor A495/A280 ratios and
should not be directly compared to sfWT (RscG232 and AscG230).
Improvements to refolding are 3-fold for RscG224 and 4.5-fold for
RscG+15.
doi:10.1371/journal.pone.0064363.g010
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lost. In a positive-supercharge design, the AvNAPSA method
removed an aspartate that was making a sidechain-backbone
hydrogen bond in a surface loop. Right: In a positive-supercharge
design, Rosetta mutated a partially buried residue to add a salt-
bridge hydrogen bond.
(TIF)
Figure S2 Atom-based versus residue-based definition
of surface residues. Rosetta typically defines surface residues as
having ,16 neighboring residues with Cb- Cb distances ,10 A˚.
The AvNAPSA protocol is named after how it defines surface
residues: by the Average Neighboring Atoms Per Sidechain Atom
(10 A˚ neighbor distance cutoff). The residue-based definition is not
sensitive to change in sequence or sidechain rotamer. These two
definitions can vary in which residues are identified as part of
surface, and the Rosetta-supercharge protocol can use either
definition. Values in the plot are derived from surface definitions
of 600 monomeric proteins.
(TIF)
Figure S3 Top: Rosetta supercharge varies net charge by
adjusting the reference energy of the desired charged-residue
types. Bottom: AvNAPSA varies net charge by adjusting the
atom-based surface cutoff (AvNAPSA value). GFP is represented
in green cartoon, and arginine/lysine mutations are represented in
blue spheres. Wedges represent increasing/decreasing net charge.
(TIF)
Figure S4 Computed energy changes for high-charge
variants for each score term. AvNAPSA variants had a fixed
surface cutoff (AvNAPSA value ,150), and Rosetta variants were
designed to reach the same net charge. AvNAPSA variant energies
get worse in many terms (empty bars), while Rosetta variant
energies are preserved (solid bars). Rosetta variants were designsed
using altered reference energies but were scored using the default
reference energies. See Figure 5 of the main text for the same
analysis of low-charge variants.
(TIF)
Figure S5 Rosetta can place charged side chains to form
new hydrogen bonds. Relevant side-chain and backbone atoms
are shown in sticks, Rosetta mutations are colored orange, wild-
type side chains and backbones are colored green, and hydrogen
bonds are represented in black dashes.
(TIF)
Figure S6 Rosetta can mutate 15 residue types, Av-
NAPSA can mutate 4 residue types. AvNAPSA conserva-
tively mutates exposed flexible polar residues for minimal change
to the surface characteristics (empty bars). When searching for
favorable mutations, Rosetta can mutate all residue types except
glycine, proline, and cysteine (solid bars). Mutating surface
hydrophobic residues, for example, reduces hydrophobic content
and might help prevent aggregation of the unfolded state.
(TIF)
Figure S7 Residues mutated by Rosetta supercharge
have more atom neighbors than residues mutated by
AvNAPSA supercharge. AvNAPSA, by definition, targets
residues with lowest AvNAPSA values. Rosetta mutates less-
exposed residues to add more favorable contacts.
(TIF)
Figure S8 AvNAPSA requires fewer mutations to ac-
complish a target net charge. AvNAPSA mutations are
limited to NQ and DE/RK residues, giving a ,50% chance of a
charge swap. Rosetta can mutate many uncharged residues, so it
requires closer to one mutation per charge addition.
(TIF)
Figure S9 Recovery of fluorescent GFP from the pellet
after centrifugation of cell lysates. After lysis and centrifu-
gation, treatment of pelleted fractions with 5 M NaCl increased
yields of positively-charged GFP variants.
(TIF)
Figure S10 Superfolder GFP (sfGFP) refolding is dimin-
ished by increased incubation times at 956C. High-
temperature incubation at 1 minute leads to .50% refolding,
while incubation at 5 minutes leads to ,5% refolding.
(TIF)
Figure S11 Percentage of fluorescence recovered while
recovering at 256C after heating to 956C for 3 minutes.
Rosetta variants (bold lines) and AvNAPSA variants (thin lines)
show similar refolding percentages. The negative variants Asc-30
and Rsc-32 have lower A495/A280 ratios than sfWT, so percent
refolding is not a fair metric to compare these designed variants
and sfWT. sfGFP refolds to 8% fluorescence recovery.
(TIF)
Table S1 Number of computed hydrogen bonds lost/
gained per supercharged structure.
(DOC)
Text S1 Supporting information.
(DOC)
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